Blaine Davis
Chief Accounting Officer
Cartesian Therapeutics, Inc. (RNAC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-11-28–present
-
Current
2020-02-11–present
-
Current
-
Start not stated–2022-07-15
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cartesian Therapeutics, Inc. (RNAC) | Chief Financial Officer | $475,860 | $1,949,927 |
| 2024 | Cartesian Therapeutics, Inc. (RNAC) | Chief Financial Officer | $462,000 | $3,971,412 |
| 2023 | Cartesian Therapeutics, Inc. (RNAC) | Chief Financial Officer | $440,000 | $2,494,759 |
| 2022 | Cartesian Therapeutics, Inc. (RNAC) | Chief Financial Officer | $33,846 | $1,263,706 |
| 2022 | Protara Therapeutics, Inc. (TARA) | Former Chief Financial Officer | $228,667 | $1,386,258 |
| 2021 | Cartesian Therapeutics, Inc. (RNAC) | Chief Financial Officer | — | — |
| 2021 | Protara Therapeutics, Inc. (TARA) | Former Chief Financial Officer | $409,303 | $1,750,006 |
| 2020 | Protara Therapeutics, Inc. (TARA) | Chief Financial Officer | $343,367 | $3,383,602 |
| 2019 | Protara Therapeutics, Inc. (TARA) | Chief Financial Officer | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.